These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1032 related articles for article (PubMed ID: 31308326)
1. Ivabradine Improves Cardiac Function and Increases Exercise Capacity in Patients with Chronic Heart Failure. Pei H; Miao W; Xie WZ; Wang W; Zhao D; Su GH; Zhao Z Int Heart J; 2019 Jul; 60(4):899-909. PubMed ID: 31308326 [TBL] [Abstract][Full Text] [Related]
2. Impact of ivabradine on the cardiac function of chronic heart failure reduced ejection fraction: Meta-analysis of randomized controlled trials. Bryan Richard S; Huang B; Liu G; Yang Y; Luo S Clin Cardiol; 2021 Apr; 44(4):463-471. PubMed ID: 33638556 [TBL] [Abstract][Full Text] [Related]
3. A Systematic Review and Meta-Analysis of Randomised Controlled Trials Assessing Clinical and Haemodynamic Outcomes of Ivabradine in Heart Failure With Reduced Ejection Fraction Patients. Waranugraha Y; Rizal A; Tjahjono CT; Vilado IY; David NI; Abudan F; Setyaningrum DA Heart Lung Circ; 2024 Jul; 33(7):962-974. PubMed ID: 38729854 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials. Lei L; Liu Y BMC Cardiovasc Disord; 2017 Jul; 17(1):196. PubMed ID: 28738783 [TBL] [Abstract][Full Text] [Related]
9. Effects of treatment on exercise tolerance, cardiac function, and mortality in heart failure with preserved ejection fraction. A meta-analysis. Holland DJ; Kumbhani DJ; Ahmed SH; Marwick TH J Am Coll Cardiol; 2011 Apr; 57(16):1676-86. PubMed ID: 21492765 [TBL] [Abstract][Full Text] [Related]
10. [Efficacy and safety analysis of ivabradine hydrochloride treatment of Chinese patients with chronic heart failure: subgroup analysis of Chinese patients in the SHIFT study]. Hu DY; Huang DJ; Yuan ZY; Zhao RP; Yan XW; Wang MH; Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Mar; 45(3):190-197. PubMed ID: 28316174 [No Abstract] [Full Text] [Related]
11. Efficacy of ivabradine in heart failure patients with a high-risk profile (analysis from the SHIFT trial). Abdin A; Komajda M; Borer JS; Ford I; Tavazzi L; Batailler C; Swedberg K; Rosano GMC; Mahfoud F; Böhm M; ESC Heart Fail; 2023 Oct; 10(5):2895-2902. PubMed ID: 37427483 [TBL] [Abstract][Full Text] [Related]
12. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life. Abdel-Salam Z; Rayan M; Saleh A; Abdel-Barr MG; Hussain M; Nammas W Cardiol J; 2015; 22(2):227-32. PubMed ID: 25179314 [TBL] [Abstract][Full Text] [Related]
13. Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial. Kosmala W; Holland DJ; Rojek A; Wright L; Przewlocka-Kosmala M; Marwick TH J Am Coll Cardiol; 2013 Oct; 62(15):1330-8. PubMed ID: 23916925 [TBL] [Abstract][Full Text] [Related]
14. Impact of Ivabradine on Health-Related Quality of Life of Patients with Ischaemic Chronic Heart Failure. Sallam M; Al-Saadi T; Alshekaili L; Al-Zakwani I Curr Vasc Pharmacol; 2016; 14(5):481-486. PubMed ID: 27145825 [TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of Qishen granules in patients with chronic heart failure: study protocol for a randomized controlled trial. Wang J; Shi J; Wei J; Wang J; Gao K; Li X; Chen J; Li S; Zhao H; Wang W Trials; 2017 Oct; 18(1):468. PubMed ID: 29017565 [TBL] [Abstract][Full Text] [Related]
16. Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients. Ngo K; Kotecha D; Walters JA; Manzano L; Palazzuoli A; van Veldhuisen DJ; Flather M Cochrane Database Syst Rev; 2010 Jan; (1):CD007613. PubMed ID: 20091643 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Inorganic Nitrate Versus Placebo Treatment in Heart Failure with Preserved Ejection Fraction. Gui Y; Chen J; Hu J; Ouyang M; Deng L; Liu L; Sun K; Tang Y; Xiang Q; Xu J; Zhu L; Peng Z; Zou P; Li B; Zheng Z; Xu D Cardiovasc Drugs Ther; 2020 Aug; 34(4):503-513. PubMed ID: 32394177 [TBL] [Abstract][Full Text] [Related]
18. Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction: The METEORIC-HF Randomized Clinical Trial. Lewis GD; Voors AA; Cohen-Solal A; Metra M; Whellan DJ; Ezekowitz JA; Böhm M; Teerlink JR; Docherty KF; Lopes RD; Divanji PH; Heitner SB; Kupfer S; Malik FI; Meng L; Wohltman A; Felker GM JAMA; 2022 Jul; 328(3):259-269. PubMed ID: 35852527 [TBL] [Abstract][Full Text] [Related]
19. The impact of exercise training for chronic heart failure patients with cardiac resynchronization therapy: A systematic review and meta-analysis. Guo R; Wen Y; Xu Y; Jia R; Zou S; Lu S; Liu G; Cui K Medicine (Baltimore); 2021 Apr; 100(13):e25128. PubMed ID: 33787595 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Ivabradine in Japanese Patients With Chronic Heart Failure - J-SHIFT Study. Tsutsui H; Momomura SI; Yamashina A; Shimokawa H; Kihara Y; Saito Y; Hagiwara N; Ito H; Yano M; Yamamoto K; Ako J; Inomata T; Sakata Y; Tanaka T; Kawasaki Y; Circ J; 2019 Sep; 83(10):2049-2060. PubMed ID: 31391387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]